Concise Analysis of the International Radiopharmaceuticals Market - WKRN News 2

Concise Analysis of the International Radiopharmaceuticals Market

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, February 14, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/s3prsz/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments:

  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals.

The report profiles 69 companies including many key and niche players such as:

  • Actinium Pharmaceuticals Inc.
  • Advanced Medical Isotope Corporation
  • Alseres Pharmaceuticals Inc.
  • Bayer HealthCare Pharmaceuticals
  • Bracco Diagnostics Inc.
  • Cardinal Health Inc.
  • Covidien Plc
  • Eli Lilly and Company
  • Erigal Limited
  • EUSA Pharma (Europe) Ltd.
  • GE Healthcare
  • IBA Group
  • Immunomedics Inc.
  • Jubilant Life Sciences Limited
  • Lantheus Medical Imaging Inc.
  • Medi-Radiopharma Ltd.
  • Nordion Inc.
  • Peregrine Pharmaceuticals Inc.
  • PETNET Solutions Inc.
  • Positron Corporation
  • Singapore Radiopharmaceuticals Pte Ltd.
  • Triad Isotopes Inc.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

For information on site licence pricing please click on Enquire before buying.


Key Topics Covered:

I. Introduction, Methodology & Product Definitions

II. Executive Summary
1. Industry Overview
2. Growth Drivers & Trends
3. Market Challenges
4. Therapeutic Radiopharmaceutical Products Under Development
5. Imaging Agents - An Overview
6. Nuclear Medicine - An Overview
7. Product Overview
8. Product Innovations/Introductions
9. Product Innovations/Introductions In Recent Past- A Perspective Builder
10. Recent Industry Activity
11. Corporate Activity In The Recent Past - A Perspective Builder
12. Focus On Select Players
13. Global Market Perspective

III. Market
1. The United States
2. Canada
3. Japan
4. Europe
5. Asia-Pacific
6. Middle East
7. Latin America

IV. Competitive Landscape
Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79)

  • The United States (36)
  • Canada (2)
  • Japan (1)
  • Europe (28)
  • France (2)
  • Germany (2)
  • The United Kingdom (4)
  • Italy (2)
  • Spain (1)
  • Rest of Europe (17)
  • Asia-Pacific (Excluding Japan) (9)
  • Latin America (1)
  • Africa (1)
  • Middle East (1)

For more information visit http://www.researchandmarkets.com/research/s3prsz/radiopharmaceutica


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

  • HealthMore>>

  • FDA to propose e-cigarette regulations

    FDA to propose e-cigarette regulations

    © FDA© FDA
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
  • People seek out health info when famous person dies

    People seek out health info when famous person dies

    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
  • 1 in 13 U.S. schoolkids takes psych meds

    1 in 13 U.S. schoolkids takes psych meds

    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>
    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WKRN (Young Broadcasting station). All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.